394 results on '"Churchyard, Gavin J."'
Search Results
2. Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB)
3. IFN-γ independent markers of Mycobacterium tuberculosis exposure among male South African gold miners
4. Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial
5. Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial
6. New opportunities in tuberculosis prevention: implications for people living with HIV
7. The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis
8. Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings
9. Tuberculosis Infectiousness and Host Susceptibility
10. Research Roadmap for Tuberculosis Transmission Science : Where Do We Go From Here and How Will We Know When We’re There?
11. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
12. A stratified approach to tuberculosis treatment
13. Epidemiologic studies and novel clinical research approaches that impact TB vaccine development
14. Correction to: Small contribution of gold mines to the ongoing tuberculosis epidemic in South Africa: a modeling-based study
15. Small contribution of gold mines to the ongoing tuberculosis epidemic in South Africa: a modeling-based study
16. Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF
17. Applying Ethical Principles to International Community-Based Research: A Case Study from the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE)
18. Impact of Targeted Tuberculosis Vaccination Among a Mining Population in South Africa: A Model-Based Study
19. Strategies to Accelerate HIV Care and Antiretroviral Therapy Initiation After HIV Diagnosis: A Randomized Trial
20. Controlling latent TB tuberculosis infection in high-burden countries: A neglected strategy to end T
21. Recurrent Tuberculosis: Relapse, Reinfection, and HIV
22. Implementing a Large-Scale Systematic Tuberculosis Screening Program in Correctional Facilities in South Africa
23. Thibela TB: Design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa
24. Tuberculosis Preventive Therapy in the Era of HIV Infection: Overview and Research Priorities
25. Introduction: Tuberculosis and HIV Coinfection: Current State of Knowledge and Research Priorities
26. Clinic-level factors influencing patient outcomes on antiretroviral therapy in primary health clinics in South Africa
27. Does Tuberculosis Increase HIV Load?
28. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial
29. Stable Incidence Rates of Tuberculosis (TB) among Human Immunodeficiency Virus (HIV)-Negative South African Gold Miners during a Decade of Epidemic HIV-Associated TB
30. Achieving the health Millennium Development Goals for South Africa: challenges and priorities
31. Performance of a Novel Algorithm Using Automated Digital Microscopy for Diagnosing Tuberculosis
32. Tuberculosis Control in South African Gold Mines: Mathematical Modeling of a Trial of Community-Wide Isoniazid Preventive Therapy
33. Molecular Epidemiology of Mycobacterium tuberculosis among South African Gold Miners
34. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response
35. Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status/Recherche des symptomes de la tuberculose a l'initiative du prestateur de services au Zimbabwe : valeur diagnostique et effet du statut VIH/Cribado de sintomas de tuberculosis a instancias del profesional en Zimbabwe: valor diagnostico y efecto de la serologia VIH
36. High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
37. A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control
38. Durable HIV RNA resuppression after virologic failure while remaining on a first-line regimen: a cohort study
39. Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa
40. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program
41. Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model
42. Algorithm-guided empirical tuberculosis treatment for people with advanced HIV (TB Fast Track): an open-label, cluster-randomised trial
43. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment
44. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa
45. Resistance to Mycobacterium tuberculosis infection among highly TB exposed South African gold miners.
46. A novel HIV treatment model using private practitioners in South Africa
47. Twelve-monthly versus six-monthly radiological screening for active case-finding of tuberculosis: a randomised controlled trial
48. Contrasting Reasons for Discontinuation of Antiretroviral Therapy in Workplace and Public-Sector HIV Programs in South Africa
49. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study
50. Adverse events with isoniazid preventive therapy: experience from a large trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.